Local News
27/02/2015
Bayer: strong business momentum continues and portfolio transformation underway

Group portfolio to focus on Life Sciences / All subgroups contribute to record sales and earnings / Recently launched products drive growth momentum / Group sales EUR 42,239 million (plus 5.2 percent / Fx & portfolio adj. plus 7.2 percent) / EBIT advances by 11.6 percent to EUR 5,506 million / EBITDA before special items up by 4.9 percent to EUR 8,812 million / Net income increases 7.4 percent to EUR 3,426 million / Core earnings per share up 7.3 percent to EUR 6.02 / Forecast for 2015: further sales growth and clear improvement in earnings

» more
09/12/2014
Global Youth Ag-Summit will take place in Australia in 2015

Canberra, October 2, 2014 – Every day the world’s population increases by 233,000 people, growing from 7.2 billion people today to more than 9 billion by 2050, according to estimates by the United Nations.

» more
Bayer Global News
Jan 07,2009
Visanne® - new long-term treatment for endometriosis submitted for registration in Europe
Berlin, January 7, 2009 – Bayer Schering Pharma AG, Germany, has submitted Visanne® for the treatment of endometriosis for registration to all Member States of the European Community. The Netherlands will serve as the Reference Member State for the Decentralized Procedure to receive European-wide Marketing Authorization. Visanne contains 2 mg of Dienogest and is administered orally once a day. In contrast to other drugs used for the treatment of this chronic gynecological disease, Visanne is an endometriosis-specific therapy for the long-term treatment of endometriosis. The current standard-therapy with GnRH analogue is only suitable for short-term treatment due to severe side-effects. » more
About Bayer
Working to create value through innovation and growth

Bayer is an international, research-based group with major businesses in health care, nutrition and high-tech materials.

» more
  
Bayer’s Products
Innovation and Growth in Focus

To sharpen our focus on innovation and growth, we have carried out a strategic realignment, placing our businesses into three subgroups that

» more
  
Sustainability and Commitment
Our role as a responsible corporate citizen

Bayer is committed to the concept of sustainable development: with economy

» more
  
Jobs & Career
Our employees and our human resources policy are our key strengths

“We know that the skills, commitment and motivation of our employees are the keys to our corporate success"

» more
  
Search
Publications
Links
Bayer TV
Calendar